ReviewOncoTargets and therapy2023
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks.
Pablo Mandó et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewOncoTargets and therapy2023
Pablo Mandó et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.